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Introduction
Some mushrooms are known to have strong antioxidant
capacity [1]. There is an accepted relationship between the
physiopathology of several chronic diseases and oxidative
stress. Therefore, the use of foods such as those mushrooms
with antioxidant capacity, as phytochemical protectors, may
be relevant for the prevention of oxidative stress related
diseases such as cancer. Additionally, mushrooms have been
described as a source of potential antitumour molecules,
making them attractive candidates for drug discovery [2,3].
However, there are no such studies on the Portuguese wild
mushrooms Lepista inversa and Clitocybe alexandri.
Materials and methods
Samples of Clitocybe alexandri (Gillet) Konrad
(Tricholomataceae) and Lepista inversa (Scop.: Fr.) Pat.
(Tricholomataceae) were collected in Bragança (Northeast
Portugal), in autumn 2008. Taxonomic identification was
made according to different authors and representative
voucher specimens were deposited at the herbarium of
Escola Superior Agrária of Instituto Politécnico de Bragança.
Both species are saprotrophic and edible. The samples were
lyophilised and reduced to a fine dried powder.
The extracts studied were methanolic, ethanolic and
polissacharidic.
For the antioxidant activity the following assays were used:
evaluation of DPPH (2,2-diphenyl-1-picrylhydrazyl) radical
scavenging capacity, reducing power and inhibition of lipid
peroxidation (LPO) measured in liposome solutions [4].
For the analysis of extract-induced cell growth inhibition the
SRB (sulforhodamine B) assay [5] was used, following
treatment of four tumour cell lines (lung, breast, colon and
gastric cancer) with the different extracts.
All extracts presented antioxidant activity, the most potent
being the polysaccharidic extract of Lepista inversa (EC50 <
1.8 ± 0.1 mg/ml). Regarding the growth inhibitory activity in
human tumour cell lines, the ethanolic extract of Clitocybe
alexandri was the most potent (GI50 < 17.95 ± 1.3 µg/ml in
all cell lines).
Results and discussion
Table 1. Antioxidant activity of mushrooms extracts. 
Results are expressed as EC50 (concentrations of extract in mg/ml that cause 50% of antioxidant activity, unless for reducing power that is 0.5 of
absorbance), and show means SEM of 3 independent observations.
Table 2. Effects of mushrooms extracts on the growth of human tumour cell lines.
Results are expressed as GI50 (concentrations of extract in µg/ml that cause 50% of growth inhibition of human tumour cell lines), and show 
means SEM of 3-6 independent observations performed in duplicate.g
In summary, polysaccharidic extract of Lepista inversa was
the most potent as antioxidant, while the ethanolic extract
of Clitocybe alexandri was the most potent as inhibitor of
growth of human tumour cell lines. This interesting growth
inhibitory activity proves that this mushroom, particularly
the ethanolic extract is a promising source of bioactive
compounds. As far as we know, there are no reports of
growth inhibitory activity of the studied species against lung,
colon and gastric human cancer cells. Future work will
elucidate the mechanism of action of these extracts leading
to the observed cell growth inhibition.
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Objective
The aim of the present work was to study extracts obtained
from the wild mushrooms Lepista inversa and Clitocybe
alexandri for the in vitro antioxidant activity and growth
inhibitory activity in human tumour cell lines.
Species Extracts (%)
Phenolics
(mg GAEs/g)
DPPH scavenging 
activity
Reducing power
β-carotene bleaching 
inhibition
Clitocybe alexandri
Methanolic 47.7 ± 5.3 a 1.5 ± 0.1 a 28.7 ± 3.2 a 7.0 ± 0.4 a 4.5 ± 0.2a
Ethanolic 3.5 ± 0.2 6.3 ± 0.4 10.7 ± 0.8 2.3 ± 0.0 3.7 ± 0.1 
Polysaccharides 30.3 ± 2.8 - 2.5 ± 0.0 0.9 ± 0.0 1.2 ± 0.0
Lepista inversa
Methanolic 39.0 ± 1.9 a 3.6 ± 0.1 a 10.6 ± 1.1 a 2.9 ± 0.1 a 1.1 ± 0.1 a
Ethanolic 4.6 ± 0.5 10.8 ± 0.7 9.3 ± 0.5 1.4 ± 0.1 1.5 ± 1.1
Polysaccharides 32.2 ± 3.1 - 1.8 ± 0.1 0.7 ± 0.0 0.9 ± 0.1
Species Extracts
NCI-H460
(lung cancer)
MCF-7
(breast cancer)
HCT-15 
(colon cancer)
AGS
(gastric cancer)
Clitocybe alexandri
Methanolic 34.85 ± 2.8 34.2 ± 1.4 36.9 ± 3.1 36.1 ± 2.3
Ethanolic 24.8 ± 2.3 17.95 ± 1.3 21.7 ± 2.3 26.05 ± 1.3
Polysaccharides 24.55 ± 1.8 46.8 ± 1.6 59.1 ± 0.7 51.75 ± 0.9
Lepista inversa
Methanolic 36.3 ± 5.1 45.2 ± 3.1 39.7± 4.6 67.4 ± 5.5
Ethanolic 118.3± 2.5 79.1 ± 11.8 42.3 ± 4.5 58.5 ± 3.3
Polysaccharides 155.0± 3.5 137.4 ± 1.3 77.4 ± 5.5 99.9 ± 7.8
